Eligibility in Cancer Clinical Research: The Intersection of Discovery, Generalizability, Beneficence, and Justice

Abstract

Eligibility criteria in clinical trials limit the study population for safety and scientific purposes. The ASCO-Friends collaboration reconsiders common eligibility criteria in cancer trials and finds many to be unnecessarily restrictive. The current recommendations further their efforts to facilitate accrual and improve the generalizability of research results to practice.